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1. Introduction {#mnfr2677-sec-0040}
===============

Mammals have two types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue, which are mainly composed of white adipocytes and brown adipocytes, respectively. The abnormal accumulation of WAT in obese patients is caused by an imbalance in energy intake and energy expenditure, and is thought to be a bridge between obesity and its related complications, such as type 2 diabetes and cardiovascular disease [1](#mnfr2677-bib-0001){ref-type="ref"}. White adipocytes are specialized to store excess energy in the form of triacylglycerols, and as an important endocrine organ, WAT directly modulates metabolism by secreting various adipokines. In contrast, brown adipocytes, which are characterized by a large number of mitochondria containing uncoupling protein 1 (UCP1), directly dissipate calories as heat via uncoupling of the electron transport chain from ATP synthesis [2](#mnfr2677-bib-0002){ref-type="ref"}. In recent years, inducible beige adipocytes have been found within WAT in response to cold or β‐adrenergic stimulation [3](#mnfr2677-bib-0003){ref-type="ref"}, [4](#mnfr2677-bib-0004){ref-type="ref"}. This novel type of adipocytes shares biochemical features, such as displaying multilocular lipid droplets and comparable levels of UCP1 protein, and thermogenic potential that is similar to classical brown adipocytes; therefore, these adipocytes have been termed "beige" adipocytes. The inducibility of beige adipocytes via pharmacological and nutritional intervention positions these cells as an attractive target of obesity therapeutics [5](#mnfr2677-bib-0005){ref-type="ref"}. The process of conversion of white adipocytes into beige adipocytes is called "browning," and recent research has increasingly become focused on understanding this browning of adipose tissue. As adipose tissue plays an important role in the uptake and utilization of glucose and lipids, whole‐body metabolism disorder is closely related to adipose tissue dysfunction; however, cellular evidence that browning influences glucose and lipid metabolism in adipocytes is lacking.

The transcription factor nuclear factor E2‐related factor 2 (Nrf2)/antioxidant response element (ARE) pathway defends cells against elevated oxidative damage. Recent data have clearly shown that energy metabolism is linked to cellular redox balance control at the nuclear level via Nrf2, and activation of the Nrf2‐ARE pathway allows for elevated energy utilization. For instance, acetyl‐[l]{.smallcaps}‐carnitine was reported to induce mitochondrial biogenesis in an Nrf2‐dependent manner [6](#mnfr2677-bib-0006){ref-type="ref"}. In addition, mice treated with the potent Nrf2 inducer CDDO‐IM exhibit higher energy expenditure compared with untreated mice when fed a high‐fat diet [7](#mnfr2677-bib-0007){ref-type="ref"}. These findings suggest the possibility that other dietary Nrf2 activators, such as sulforaphane (SFN), may also have effects on cellular energy expenditure. SFN, which is a major isothiocyanate present in broccoli and other cruciferous vegetables, exhibits potent antioxidant, Nrf2 agonist, and anticancer effects. The role of SFN in obesity therapy, however, remains unclear.

Here, we investigated the effect of SFN on mitochondrial biogenesis, UCP1 expression, and mitochondrial function in mature 3T3‐L1 adipocytes in order to elucidate the underlying mechanism. Moreover, we also analyzed the glucose and lipid metabolism in SFN‐treated 3T3‐L1 adipocytes. Our data revealed that SFN induces the browning of 3T3‐L1 white adipocytes by promoting mitochondrial biogenesis via upregulation of sirtuin1/peroxisome proliferator activated receptor gamma coactivator 1 alpha (Sirt‐1/PGC‐1α) signaling and enhancement of mitochondrial function. Furthermore, these results also demonstrate that glucose uptake and oxidative utilization, lipolysis, and fatty acid (FA) oxidation are upregulated in SFN‐treated 3T3‐L1 adipocytes. In sum, our results clearly identify SFN as a potential agent for protecting against obesity and the related glucose and lipid metabolism disorders by the induction of adipocyte browning.

2. Materials and methods {#mnfr2677-sec-0050}
========================

2.1. Materials {#mnfr2677-sec-0060}
--------------

3T3‐L1 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). [d]{.smallcaps}, [l]{.smallcaps}‐SFN was purchased from Toronto Research Chemical, Inc. (Toronto, Canada). The details of the remaining reagents can be found in the Supporting Information.

2.2. Cell culture and adipocyte differentiation {#mnfr2677-sec-0070}
-----------------------------------------------

Murine 3T3‐L1 preadipocytes were induced to differentiate into mature adipocytes by classic cocktail method. Various concentrations of SFN (0, 0.2, 0.5, 1, 5, and 10 μM) were used to treat the mature adipocytes. The detailed method can be found in the Supporting Information.

2.3. Oil Red O staining {#mnfr2677-sec-0080}
-----------------------

Oil Red O staining was used to assess mature adipocytes and measure the lipid content in these cells. The detailed method can be found in the Supporting Information.

2.4. Mitochondrial mass measurement {#mnfr2677-sec-0090}
-----------------------------------

The matured 3T3‐L1 adipocytes were treated with SFN or left untreated for 48 h; MitoTracker Green FM (Beyotime Biotechnology, Jiangsu, China), a mitochondria‐specific dye, was used to determine the mitochondrial mass. The detailed method can be found in the Supporting Information.

2.5. Electron microscopy {#mnfr2677-sec-0100}
------------------------

Fully differentiated adipocytes were treated with 1 μM SFN or left untreated for 48 h. After a series of treatment, the mitochondria number and the total cytoplasmic area in cells were determined under electron microscopy. The detailed method can be found in the Supporting Information.

2.6. Citrate synthase activity detection {#mnfr2677-sec-0110}
----------------------------------------

Citrate synthase (CS) activity of adipocytes was measured using the kit available from Sigma, the detailed method can be found in the Supporting Information.

2.7. Mitochondrial complex I activity measurement {#mnfr2677-sec-0120}
-------------------------------------------------

Mature adipocytes, grown in 60‐mm culture dishes, were treated with SFN for 48 h, and mitochondrial complex I activity was measured using the complex I enzyme activity microplate assay kit. The detailed method can be found in the Supporting Information.

2.8. Glucose uptake analysis {#mnfr2677-sec-0130}
----------------------------

The fluorescent [d]{.smallcaps}‐glucose analog 2‐(N‐(7‐nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl)amino)‐2‐deoxyglucose (2‐NBDG) was used as a fluorescent indicator to evaluate glucose uptake in adipocytes treated with SFN for 48 h. The fluorescence intensity at 465 nm was read using a fluorescent microplate reader to quantitate glucose uptake after 2‐NBDG incubation. The detailed method can be found in the Supporting Information.

2.9. Lipolysis assay {#mnfr2677-sec-0140}
--------------------

The release of glycerol into the culture media was detected using glycerol colorimetric assay kit to evaluate the effect of SFN on lipolysis of adipocytes. The detailed method can be found in the Supporting Information.

2.10. Real‐time quantitative PCR {#mnfr2677-sec-0150}
--------------------------------

3T3‐L1 adipocytes were treated with SFN or left untreated for 48 h. Total RNA was isolated from 3T3‐L1 mature adipocytes, and then real‐time quantitative PCR analysis was used to evaluate the relative mRNA levels of acetyl‐CoA carboxylase (ACC) and fatty acid synthase (FAS). The detailed method can be found in the Supporting Information.

2.11. Western blot analysis {#mnfr2677-sec-0160}
---------------------------

Mature adipocytes were treated with SFN or left untreated for 48 h, and the levels of indicated proteins were measured by Western blot. The detailed method can be found in the Supporting Information.

2.12. Intracellular ATP determination {#mnfr2677-sec-0170}
-------------------------------------

CellTiter‐GloLuminescent Cell Viability Assay system (Promega Corporation, Beijing, China) was used to detect the levels of ATP in adipocytes treated with or without SFN for 48 h. ATP level was presented as relative light unit (RLU) adjusted by cell number for either control or SFN‐treated cells. The detailed method can be found in the Supporting Information.

2.13. Statistical analysis {#mnfr2677-sec-0180}
--------------------------

All data are representative of at least three independent experiments. Data are expressed as means ± SD. Statistical evaluation was performed using one‐way ANOVA with the Students--Newman--Keuls test. *p* Values of less than 0.05 were considered statistically significant.

3. Results {#mnfr2677-sec-0190}
==========

3.1. SFN increases adipocyte mitochondrial biogenesis in association with regulation of the Nrf2/Sirt‐1/PGC‐1α pathway {#mnfr2677-sec-0200}
----------------------------------------------------------------------------------------------------------------------

Ten days after differentiation (D~10~) was initiated, *\>*95% of 3T3‐L1 preadipocytes were mature adipocytes containing Oil Red O positive lipid droplets. The mature adipocytes were then treated with SFN (0, 0.2, 0.5, 1, 5, and 10 μM) for 48 h. To accurately assess the mitochondrial content, MitoTracker Green FM was used to stain mitochondria in live cells. SFN treatment resulted in an increase in fluorescence intensity, with a maximum in adipocytes treated with 1 μM SFN (Fig. [1](#mnfr2677-fig-0001){ref-type="fig"}A). To further confirm the beneficial effects of SFN on mitochondrial biogenesis, we examined adipocyte morphology in more detail using electron microscopy (Fig. [1](#mnfr2677-fig-0001){ref-type="fig"}B). Quantitative analysis showed that SFN (1 μM) treatment caused a significant increase in mitochondrial intensity (i.e., the average number of mitochondria in the total cytoplasmic area per cell) compared with control treatment (Fig. [1](#mnfr2677-fig-0001){ref-type="fig"}C; *p* \< 0.05). We also examined the Sirt‐1/PGC‐1α pathway to clarify the underlying mechanism for the increased mitochondrial biogenesis. Sirt‐1 was significantly increased in SFN‐treated adipocytes (Fig. [2](#mnfr2677-fig-0002){ref-type="fig"}; *p* \< 0.05). Interestingly, Sirt‐1 protein expression was most enhanced in adipocytes treated with 1 μM SFN. PGC‐1α, a downstream target of Sirt‐1, was also significantly increased in the adipocytes treated with SFN (0, 0.2, 0.5, 1, 5, and 10 μM; *p* \< 0.05). Furthermore, the level of nuclear respiratory factor 1 (NRF‐1) protein, which is a downstream target of PGC‐1α, significantly increased, similar to PGC‐1α (*p* \< 0.05). In addition, SFN treatment markedly increased the Nrf2 protein level (*p* \< 0.05).

![Effect of SFN on the mitochondrial content of mature 3T3‐L1 adipocyte. The cells were treated with 0, 0.2, 0.5, 1, 5, and 10 μM SFN for 48 h. (A) The mitochondrial mass was obtained using the Mitotracker Green stain (magnification, ×60). (B) The mitochondrial ultrastructure image was generated using a transmission electron microscope (magnification, ×5,000). (C) The mitochondria density in adipocytes was detected using a transmission electron microscope. Values indicate means ± SD of six cells. \**p* \< 0.05 compared with the control.](MNFR-60-2185-g001){#mnfr2677-fig-0001}

![Effects of SFN on the expression of Sirt‐1, PGC‐1α, NRF‐1, and Nrf2 in 3T3‐L1 mature adipocytes treated with the indicated concentrations of SFN for 48 h. (A) Representative Western blots. (B) Relative quantitative analysis of proteins. Results are presented as percentages relative to control cells. Data are shown as means ± SD of three independent experiments. \**p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g002){#mnfr2677-fig-0002}

3.2. SFN increases adipocyte mitochondrial activity and the expression of UCP1 {#mnfr2677-sec-0210}
------------------------------------------------------------------------------

To confirm whether the increased mitochondrial biogenesis was associated with elevated mitochondrial activity, we first examined the effect of SFN on CS, a marker of mitochondrial aerobic capacity. As shown in Fig. [3](#mnfr2677-fig-0003){ref-type="fig"}A, SFN treatment markedly increased the activity of CS with maximum enzyme activity observed at an SFN concentration of 1 μM. Similarly, SFN also significantly elevated the activity of mitochondrial complex I on the respiratory chain (*p* \< 0.05; Fig. [3](#mnfr2677-fig-0003){ref-type="fig"}B). To further evaluate mitochondrial function, the level of intracellular ATP was also measured. Accordingly, SFN induced a decrease in the ATP level (Fig. [3](#mnfr2677-fig-0003){ref-type="fig"}C). Next, Western blot analysis revealed that the expression of UCP1, a specific brown adipocyte protein, in 3T3‐L1 white adipocytes exposed to SFN was markedly induced (*p* \< 0.05) with a maximal UCP1 protein expression at 1 μM SFN (Fig. [4](#mnfr2677-fig-0004){ref-type="fig"}).

![Effect of SFN on mitochondrial function. Mature 3T3‐L1 adipocytes were treated with the indicated concentrations of SFN for 48 h. (A) CS enzyme activity. (B) Mitochondrial complex I activity. (C) The intracellular ATP level. Results are presented as percentages relative to control. Values are means ± SD of three experiments. \**p* \< 0.05 compared with control.](MNFR-60-2185-g003){#mnfr2677-fig-0003}

![Effects of SFN on the expression of UCP1 in mature 3T3‐L1 adipocytes treated with SFN for 48 h. Upper: representative Western blot. Lower: quantification of UCP 1 protein expression. Results are presented as percentages relative to the control. Data are means ± SD of three independent experiments. \**p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g004){#mnfr2677-fig-0004}

3.3. SFN stimulates glucose uptake, enhanced glucose aerobic oxidation related gene expression and inhibits de novo FA synthesis related gene expression {#mnfr2677-sec-0220}
--------------------------------------------------------------------------------------------------------------------------------------------------------

The fluorescent nontoxic [d]{.smallcaps}‐glucose analog 2‐NBDG is commonly used as a probe indicator for the rapid and direct detection of glucose uptake into cells. Thus, we employed 2‐NBDG for the detection of glucose uptake in mature 3T3‐L1 adipocytes exposed to different doses of SFN for 48 h. The fluorescence intensity of 2‐NBDG was qualitatively and quantitatively measured using confocal microscopy and a multifunctional microplate reader, respectively. Confocal microscopy revealed that SFN induced glucose uptake in adipocytes, with a maximum in adipocytes treated with 1 μM SFN (Fig. [5](#mnfr2677-fig-0005){ref-type="fig"}A). The quantitative results confirmed this trend (Fig. [5](#mnfr2677-fig-0005){ref-type="fig"}B). Additionally, glucose transporter type 4 (GLUT‐4) is a glucose transporter expressed in adipose tissue and is responsible for the transport of glucose into adipocytes. SFN treatment markedly increased the expression of GLUT‐4 (Fig. [5](#mnfr2677-fig-0005){ref-type="fig"}C). After being transported into adipocytes, glucose is normally converted into pyruvate via the glycolytic pathway mediated by hexokinase or glucokinase (GCK), while pyruvate is subsequently transferred into the mitochondria for conversion into acetyl‐CoA. Most of the acetyl‐CoA enters the tricarboxylic acid cycle to generate energy via the action of CS. Conversely, acetyl‐CoA that is derived from glucose and FA oxidation may return to the cytosol to participate in de novo synthesis of FAs via key enzymes, such as ACC and FAS. In this study, the protein and mRNA levels of key enzymes involved in glucose aerobic oxidation, including GCK and CS, as well as key enzymes involved in FA synthesis, such as ACC and FAS, were measured in 3T3‐L1 adipocytes using Western blot and real‐time quantitative PCR, respectively; this was done in order to examine the mechanism used by SFN to direct the metabolic fate of glucose in cells. Results of Western blotting showed that the levels of GCK and CS, indispensable to glucose oxidation, were significantly upregulated in beige adipocytes induced by SFN (Fig. [5](#mnfr2677-fig-0005){ref-type="fig"}C; *p* \< 0.05),while real‐time PCR indicated that the expression of ACC and FAS genes, key enzymes involved in endogenous synthesis of FAs was significantly inhibited (Fig. [5](#mnfr2677-fig-0005){ref-type="fig"}D).

![Effect of SFN on glucose uptake, aerobic oxidation, and de novo FA synthesis in 3T3‐L1 adipocytes. Mature adipocytes were incubated in the presence of 0--10 μM SFN for 48 h. Glucose uptake was monitored using 2‐NBDG as a fluorescent probe. (A) Representative images of glucose uptake were captured by confocal microscopy. (B) Quantitative analysis of fluorescence intensity was determined using multifunctional microplate reader. (C) Expressions of membrane protein GLUT‐4 and glucose oxidative metabolism enzymes GCK and CS were measured using Western blot. Upper: representative Western blot. Lower: quantification of proteins levels. (D) The mRNA levels of the de novo FA synthesis enzymes ACC and FAS were determined by real‐time quantitative PCR. Results are presented as percentages relative to the control. Data are means ± SD of three independent experiments. \**p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g005){#mnfr2677-fig-0005}

3.4. SFN increases lipolysis, elevates the expression of genes responsible for FA oxidation, and decreases the protein level associated with triacylglyceride synthesis {#mnfr2677-sec-0230}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

The effect of SFN on lipolysis in 3T3‐L1 adipocytes was measured by quantifying the intracellular lipid content using Oil Red O staining and by monitoring the output of glycerol into the medium. SFN triggered an increase of lipolysis depicted by a bell‐shaped curve with a minimal lipid content corresponding to 1 and 5 μM SFN (Fig. [6](#mnfr2677-fig-0006){ref-type="fig"}A and B) and a maximal glycerol release corresponding to 1 μM SFN (Table [1](#mnfr2677-tbl-0001){ref-type="table-wrap"}, Fig. [6](#mnfr2677-fig-0006){ref-type="fig"}C). Further, the expression of lipid metabolism related enzymes in adipocytes was examined. Triacylglyceride (TG) is the main storage lipid in adipocytes. Lipolysis is a step‐wise process regulated by perilipin (Plin), adipose triacylglyceride lipase (ATGL), and hormone‐sensitive lipase (HSL). Plin is exclusively located on the surface layer of intracellular lipid droplets within adipocytes, and functions to protect lipid storage droplets. ATGL initiates the hydrolysis of TG into diacylglycerol (DAG) and free FAs, while HSL subsequently catalyzes the release of one additional FA from DAG. Our results demonstrated that both Plin and HSL protein expression in SFN‐treated adipocytes was significantly decreased compared with the levels in untreated adipocytes (*p* \< 0.01), whereas ATGL protein levels were not significantly elevated, although a tendency for levels to increase was noted (Fig. [7](#mnfr2677-fig-0007){ref-type="fig"}). Phosphorylation of HSL at Ser 563 and Ser 660, as stimulated by protein kinase A (PKA), led to HSL translocation to the surface of lipid droplets to promote lipolysis; however, HSL phosphorylation at Ser 565 prevents phosphorylation of HSL at Ser 563 [8](#mnfr2677-bib-0009){ref-type="ref"}. In our study, SFN increased phosphorylation of HSL at Ser 563 and Ser 660 and decreased phosphorylation at Ser 565. Therefore, these findings suggest that in SFN‐induced beige adipocytes, lipolysis is primarily mediated by Plin and HSL. Enhanced lipolysis of adipocytes may lead to an increase of free FA release, and excess circulating free FAs from the lipolysis of TG stored in white adipocytes are harmful even at relatively low concentrations, resulting in stimulation of macrophages and ultimately inflammation [9](#mnfr2677-bib-0010){ref-type="ref"}.

![Lipolysis was analyzed in adipocytes treated with the indicated concentrations of SFN for 48 h. (A) Representative image of Oil Red O staining. (B) The lipid content was quantified via detection of absorbance at 510 nm. (C) The glycerol content was used to reflect the level of lipolysis in adipocytes. *\*p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g006){#mnfr2677-fig-0006}

###### 

Glycerol output of 3T3‐L1 adipocytes treated with SFN ($\overline{x} \pm s,n = 3$)

  SFN (μM)   Glycerol content (mM)
  ---------- ------------------------------------------------------------
  0          0.798 ± 0.042
  0.2        0.913 ± 0.060[\*](#mnfr2677-tbl1-note-0002){ref-type="fn"}
  0.5        0.921 ± 0.056[†](#mnfr2677-tbl1-note-0002){ref-type="fn"}
  1.0        1.032 ± 0.045[†](#mnfr2677-tbl1-note-0002){ref-type="fn"}
  5.0        0.966 ± 0.017[†](#mnfr2677-tbl1-note-0002){ref-type="fn"}
  10.0       0.916 ± 0.056[\*](#mnfr2677-tbl1-note-0002){ref-type="fn"}

The results are presented as means ± SD of three independent experiments.

\**p* \< 0.05, ^†^ *p* \< 0.01, compared with control.

John Wiley & Sons, Ltd.

![Effect of SFN on expression of lipolysis‐related enzymes in adipocytes. Mature adipocytes were treated with indicated doses of SFN for 48 h. Total protein extracts were prepared, and levels of ATGL, Plin, HSL, p‐HSL^Ser563^, p‐HSL^Ser565^, and p‐HSL^Ser660^ were analyzed by Western blot. (A) Representative image of Western blot. (B--C) Relative quantification of protein levels. Results are presented as the percentages relative to the control. The results are presented as means ± SD of three independent experiments. *\*p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g007){#mnfr2677-fig-0007}

Therefore, an increase in the aerobic oxidation of FAs in adipocytes will be helpful in inhibiting the influx of free FAs into the bloodstream. Carnitine palmitoyltransferase 1A (CPT1A) and CS are key enzymes responsible for the aerobic oxidation of FAs. CPT1A is responsible for shuttling long‐chain FAs into mitochondria, whereas CS functions to initiate the tricarboxylic acid cycle. In the present study, SFN treatment for 48 h induced increases in CPT1A and CS expression (Fig. [8](#mnfr2677-fig-0008){ref-type="fig"}A). CPT1A increase suggested that FA β‐oxidation was increased in SFN‐induced beige adipocytes. In addition, in order to examine whether SFN affect the esterification of FAs for the synthesis of TG, the level of diacylglycerol acyl transferase (DGAT‐1) in adipocytes incubated with SFN for 48 h was measured. DGAT‐1 is a crucial enzyme that is involved in catalysis of the final step of triglyceride synthesis. In this study, DGAT‐1 protein expression was significantly decreased in SFN‐treated cells compared with expression in control cells (Fig. [8](#mnfr2677-fig-0008){ref-type="fig"}B; *p* \< 0.01).

![Effect of SFN on FA oxidation and triglyceride synthesis in adipocytes. Mature adipocytes were treated with different concentrations of SFN for 48 h. Total protein extracts were prepared, and protein levels of CPT1A, CS (key enzyme in FA aerobic oxidation), and DGAT‐1 (key enzyme in triglyceride synthesis) were analyzed by Western blot. (A) CPT1A and CS expression. Upper: representative image of Western blot. Lower: quantification of CPT1A and CS protein expression. (B) DGAT‐1 expression. Upper: representative image of Western blot. Lower: quantification of DGAT‐1 protein expression. Results are presented as percentages relative to the control. Values are means ± SD of three independent experiments. \**p* \< 0.05, \*\**p* \< 0.01 compared with the control.](MNFR-60-2185-g008){#mnfr2677-fig-0008}

4. Discussion {#mnfr2677-sec-0240}
=============

SFN is a naturally occurring organo‐sulfur compound derived from cruciferous vegetables such as broccoli, brussels sprouts, or cabbages [10](#mnfr2677-bib-0011){ref-type="ref"}. SFN is a well‐known potent natural oxidant with anticancer properties [11](#mnfr2677-bib-0012){ref-type="ref"}. SFN has also been demonstrated to inhibit adipogenesis, and improve glucose metabolism by blocking streptozotocin‐induced islet destruction [12](#mnfr2677-bib-0013){ref-type="ref"}, [13](#mnfr2677-bib-0014){ref-type="ref"}. Our previous study demonstrated that SFN can induce the apoptosis of adipocyte [14](#mnfr2677-bib-0015){ref-type="ref"}. Until now, however, little has been known about the impact of SFN on mitochondria homeostasis in adipocytes. As a result, we sought to investigate the effect of SFN on mitochondrial biogenesis and UCP1 expression in mature 3T3‐L1 adipocytes. We found that SFN strongly impacted mitochondria biogenesis and function, leading to increased mitochondrial content and oxidative capacity, and ultimately inducing white adipocyte browning. Additional data confirmed that SFN significantly enhanced the activity of CS and mitochondrial complex enzymes on the respiratory chain. More importantly, SFN markedly elevated the expression of UCP1, which is a specific protein of brown adipocyte. The cellular ATP content was decreased with the elevation of UCP1 protein level. These results indicated that SFN functions to promote the browning of adipocytes and dissipate of ATP.

To explore the mechanism responsible for this effect of SFN on 3T3‐L1 adipocytes, the PGC‐1α pathway was examined. PGC‐1α is a transcriptional coactivator that plays an important role in mitochondrial biogenesis in mammalian tissues [15](#mnfr2677-bib-0016){ref-type="ref"}. NRF‐1 is an initial transcription factor target that was identified in the induction of mitochondrial biogenesis by PGC‐1α, as manifested by PGC‐1α‐induced transactivation of NRF‐1 and stimulation of mitochondrial DNA replication and gene expression [16](#mnfr2677-bib-0017){ref-type="ref"}. In contrast, a dominant‐negative allele of NRF‐1 blocks the effects of PGC‐1α on mitochondrial biogenesis [17](#mnfr2677-bib-0018){ref-type="ref"}. Sirt‐1, an NAD^+^‐dependent protein deacetylase, has emerged as an important metabolic sensor, and its activation by small molecules, calorie restriction, or exercise promotes mitochondrial biogenesis and activities [18](#mnfr2677-bib-0019){ref-type="ref"}, [19](#mnfr2677-bib-0020){ref-type="ref"}. PGC‐1α is a principal substrate of Sirt‐1, and thus, Sirt‐1 may function, in part, by deacetylating multiple lysine residues in PGC‐1α, thereby upregulating metabolic signaling through PGC‐1α and promoting mitochondrial FA oxidation [20](#mnfr2677-bib-0021){ref-type="ref"}. As shown in our experiments, expressions of the transcription factors Sirt‐1, PGC‐1α, and NRF‐1, which are involved in mitochondrial biogenesis, were upregulated by SFN treatment in 3T3‐L1 adipocytes. Moreover, this upregulation was closely correlated with the stimulation of mitochondrial biogenesis and induction of UCP1 expression, suggesting that SFN activates the Sirt‐1/PGC‐1α pathway to promote browning of 3T3‐L1 adipocytes, as shown in Fig. [9](#mnfr2677-fig-0009){ref-type="fig"}.

![Proposed schematic diagram of SFN‐induced mitochondrial biogenesis. SFN activates the Sirt‐1/PGC‐1α pathway and enhances expression of Nrf2 and NRF‐1, thereby promoting the expressions of genes involved in mitochondrial biogenesis and triggering browning of 3T3L1 adipocytes.](MNFR-60-2185-g009){#mnfr2677-fig-0009}

Piantadosi et al. demonstrated that Nrf2 connects mitochondrial biogenesis with antioxidant defenses via the multiple Nrf2 binding sites in the NRF‐1 promoter [20](#mnfr2677-bib-0021){ref-type="ref"}. Carbon monoxide, a product of heme oxygenase 1, activates mitochondrial biogenesis in cardiomyocytes in an Nrf2‐dependent manner. In detail, carbon monoxide elevated mitochondrial H~2~O~2~ production, which induced Nrf2 nuclear translocation mediated by PKB/Akt kinase [21](#mnfr2677-bib-0022){ref-type="ref"} and occupancy of four AREs in the NRF‐1 promoter, thereby leading to gene activation for mitochondrial biogenesis. SFN is a well‐known and potent activator of Nrf2. In the present study, SFN was found to enhance Nrf2 protein expression. Of note, the effect of SFN on the browning of adipocytes occurred in a different manner with the most marked effect observed at a relative low dose (1 μM). It is still reasonable, however, to assume that Nrf2 is involved in the browning effect of SFN on 3T3‐L1 adipocytes.

Detailed understanding of how glucose and lipid metabolism occur in beige fat cells is critical for the identification and implementation of brown fat‐based therapies for obesity and related disease. Accumulating evidence supports the notion that the metabolic benefits of this conversion from white to beige cells include prevention of diet‐induced obesity and increase of insulin (INS) sensitivity [22](#mnfr2677-bib-0023){ref-type="ref"}, given that mitochondria are the central players in cellular bioenergetics and global metabolism homeostasis. Unfortunately, we lack sufficient details with respect to glucose and lipid disposal capacity of beige adipocytes. Therefore, we determined whether glucose and lipid utilization altered in SFN‐treated adipocytes that displayed a beige phenotype with enhanced mitochondrial biogenesis. Disruption in glucose homeostasis causes diseases such as diabetes mellitus and cardiovascular disorders, and glucose transporters mediate the transport of glucose from the extracellular fluid into the cytoplasm of mammalian cells [23](#mnfr2677-bib-0024){ref-type="ref"}. The GLUT‐4 system, which is mainly expressed in skeletal muscle and fat cells, is a pivotal component in the maintenance of glucose homeostasis, and this system has been widely studied due to its role in diabetes [24](#mnfr2677-bib-0025){ref-type="ref"}. Adipose is a metabolically meaningful tissue and capable of contributing to whole‐body glucose homeostasis. In INS‐resistant humans and rodents, the expression of GLUT‐4 is decreased in adipocytes compared to muscle [25](#mnfr2677-bib-0026){ref-type="ref"}. Conversely, GLUT‐4 over‐expression in adipose tissue of mice lacking GLUT‐4 selectively in muscle reverses INS resistance and diabetes [26](#mnfr2677-bib-0027){ref-type="ref"}. While increased GLUT‐4‐mediated glucose transport plays a rate‐limiting role in glucose utilization in adipose tissues [27](#mnfr2677-bib-0028){ref-type="ref"}, Heiss et al. reported that small molecule SFN increased cellular glucose uptake in mouse embryonic fibroblasts [28](#mnfr2677-bib-0029){ref-type="ref"}. Consistent with these findings, we detected an enhanced cellular uptake of glucose analog 2‐NBDG and a high level of GLUT‐4 expression in 3T3‐L1 adipocytes treated with SFN, indicating that SFN acts to stimulate glucose uptake via upregulation of GLUT‐4 in these cells. As a major energy source, glucose provides energy in the form of ATP via glycolysis and the citric acid cycle. We used detection of the levels of GCK and CS, key enzymes of glycolysis and tricarboxylic acid cycle, respectively, to track the metabolic fate of glucose in SFN‐treated adipocytes. SFN markedly elevated the expressions of GCK and CS, and thus, we propose that SFN treatment enhances mitochondrial biogenesis, thereby promoting upregulation of glucose aerobic oxidation pathway.

We also investigated the effect of browning of 3T3‐L1 adipocytes on lipid metabolism. As for lipolysis, ATGL, which is located on the surface of lipid droplets, specifically removes the first FA from the TG molecule generating DAG [29](#mnfr2677-bib-0030){ref-type="ref"}. HSL then acts to convert DAG into monoacylglycerol. Of note, TG in adipocytes is stored within lipid droplets surrounded by a phospholipid monolayer containing various lipid droplet proteins, and lipolysis involves specific protein--protein interactions at the surface of these lipid droplets [30](#mnfr2677-bib-0031){ref-type="ref"}. Plin is a lipid droplet scaffold protein and is known as a "molecular switch" of lipolysis [31](#mnfr2677-bib-0032){ref-type="ref"}. Plin functions to protect lipid storage droplets in adipocytes by coating them until digestion by HSL and promoting interactions amongst lipolytic effector proteins, thereby modulating the lipid metabolism in adipocytes [31](#mnfr2677-bib-0032){ref-type="ref"}, [32](#mnfr2677-bib-0033){ref-type="ref"}. In the basal state, Plin sequesters α/β‐fold domain‐containing protein 5, causing the inactivation of ATGL [33](#mnfr2677-bib-0034){ref-type="ref"}. Catecholamines stimulate the phosphorylation of cytosolic HSL and Plin via PKA, resulting in release of α/β‐fold domain‐containing protein 5, which is then available for ATGL. Finally, TG hydrolysis is initiated [34](#mnfr2677-bib-0035){ref-type="ref"}. As a critical regulator of lipolysis, elevated Plin levels have been linked to obesity, and by contrast, downregulation of Plin expression either with or without upregulation of p‐Plin results in destruction of the protein protective barrier on the surface of the lipid droplet and enhancement of lipolysis [33](#mnfr2677-bib-0034){ref-type="ref"}. For example, enhanced expression of Plin is necessary for the antilipolytic effect of activator minoimidazole carboxamide ribonucleotide [32](#mnfr2677-bib-0033){ref-type="ref"}. As the rate‐limiting enzyme for the lipolysis reaction [35](#mnfr2677-bib-0036){ref-type="ref"}, HSL is a major target of PKA‐catalyzed lipolysis [36](#mnfr2677-bib-0037){ref-type="ref"}, which results in phosphorylation and activation of HSL at Ser 563, Ser 659, and Ser 660 [37](#mnfr2677-bib-0038){ref-type="ref"}. Conversely, phosphorylation of HSL at Ser 565 inhibits the phosphorylation of HSL at Ser 563 by PKA. A recent study by Lee et al. showed that SFN increased lipolysis via an increase in HSL phosphorylation at Ser 563 and suppression of phosphorylation at Ser 565 without any detectable effect on Plin mRNA [12](#mnfr2677-bib-0013){ref-type="ref"}. In our study, SFN decreased the cellular lipid droplet loads and suppressed the protein expression of Plin. One possible explanation for the discrepancy between levels of Plin expression in these two studies may be that our study employed a longer SFN treatment time (48 h) than the one (24 h) used in the study by Lee et al. Our results also demonstrated that SFN significantly upregulates HSL at the protein level in adipocytes, stimulates the phosphorylation of HSL at Ser 563 and Ser 660, and inhibits the phosphorylation of HSL at Ser 565. Interestingly, a previous study showed that ATGL‐catalyzed lipolysis induced PGC‐1α signaling and downstream changes in oxidative metabolism [38](#mnfr2677-bib-0039){ref-type="ref"}; yet, in our study, SFN elevated, but did not significantly increased, the expression of ATGL. Therefore, we postulate that the SFN‐induced lipolysis enhancement may be most dependent on the activation of HSL, as ATGL was not involved in the effect of SFN on PGC‐1α signaling or on oxidative metabolism.

In general, the FAs derived from lipolysis in adipocytes are available for β‐oxidation or reassembly for storage as inert triglycerides via lipogenesis. To describe the metabolic fate of FAs, we measured the levels of CPT1A and CS, which are responsible for the influx of FAs into mitochondria and in advancement of the citric acid cycle, and the protein expression of DGAT‐1, which catalyzes the final step of TG synthesis [39](#mnfr2677-bib-0040){ref-type="ref"}. DGAT‐1 is present in adipose tissues and is believed to play a role in lipid absorption and accumulation in the fat cells. A previous report showed that transgenic overexpression of DGAT‐1 in adipose tissues resulted in whole‐body INS resistance and other metabolic disturbances, suggesting that inhibition of DGAT‐1 is a promising target for the treatment of obesity and type 2 diabetes [40](#mnfr2677-bib-0041){ref-type="ref"}. Furthermore, our results demonstrated that SFN significantly increases CPT1A and CS protein levels and simultaneously decreases the expression of DGAT‐1, suggesting that more FAs released by SFN‐enhanced lipolysis may enter the aerobic oxidation pathway than the triglyceride synthesis pathway.

In addition, acetyl‐CoA, a product of the β‐oxidation of FAs, can be used to synthesize FAs through a complex set of reaction. This process, termed de novo FA synthesis, requires two major enzymatic steps. First, ACC catalyzes the synthesis of malonyl‐CoA from acetyl‐CoA, and then FAS sequentially condenses acetyl‐CoA and malonyl‐CoA to build up long‐chain FAs. In the current study, SFN markedly inhibited the expressions of both ACC and FAS, in favor of decreasing de novo FA synthesis. Therefore, the browning of adipocytes induced by SFN may be favorable for whole‐body lipid metabolism based on evidence that this compound significantly reduced the lipid droplet load, significantly increased the gene expressions related to β‐oxidation of FAs, and significantly decreased the levels of key enzyme involved in synthesis of TG. At the same time, the de novo FA synthesis‐related protein expression was downregulated. Taken together, these data suggest that SFN‐induced browning of adipocytes is favorable for the conversion of adipose tissue from an energy storage site to a lipid burn site (Fig. [10](#mnfr2677-fig-0010){ref-type="fig"}).

![Effect of SFN on glucose and lipid metabolism in mature 3T3‐L1 adipocytes. SFN enhances glucose uptake and aerobic oxidation by upregulating expression of GLUT‐4, GCK, and CS proteins. SFN also increases lipolysis by upregulating the levels of key enzymes, such as HSL and its phosphorylated form p‐HSL^Ser563^ and p‐HSL^Ser660^, involved in lipid hydrolysis, and by inhibiting levels of Plin. Furthermore, SFN triggers FA oxidation by increasing the levels of the enzymes CPT1A and CS, which are responsible for FA β‐oxidation. In contrast, SFN also inhibits endogenous FA and triglyceride synthesis by downregulating the levels of ACC and FAS as well as DGAT‐1.](MNFR-60-2185-g010){#mnfr2677-fig-0010}

5. Conclusion {#mnfr2677-sec-0250}
=============

Phytochemicals are types of active components from natural plants with many biological functions. Therefore, it comes as no surprise that phytochemicals are a valuable resources for antiobesity drug development. Our study for the first time demonstrated that SFN functions to induce the browning of 3T3‐L1 adipocytes and that this alteration is characterized by the elevated level and function of mitochondria, as well as the increased expression of UCP1. More importantly, this study systematically evaluated the effect of browning of adipocytes on glucose and lipid metabolism pathway at the cellular level, and revealed that SFN upregulates glucose uptake and oxidative utilization as well as lipolysis and FA oxidation pathway, while suppresses the endogenous synthesis of TGs pathway. Moreover, the upregulated UCP1 expression leads to dispersion of energy as heat and the decrease in ATP level. Taken together, these findings support the notion that browning of adipocytes triggered by SFN promotes glucose and lipid utilization in adipocytes, is favourable for improving of whole‐body metabolic load, and therefore, may be considered as an appealing strategy for addressing obesity and obesity‐related diseases. Furthermore, clinical investigation is necessary to determine the potential of SFN to prevent obesity‐related metabolism disorder in humans by inducing adipocyte browning.
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